"Lymphoma, Non-Hodgkin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
MeSH Number(s)
C04.557.386.480
C15.604.515.569.480
C20.683.515.761.480
Concept/Terms
Lymphoma, Non-Hodgkin- Lymphoma, Non-Hodgkin
- Lymphoma, Non Hodgkin
- Lymphoma, Atypical Diffuse Small Lymphoid
- Lymphoma, Non-Hodgkin's
- Lymphoma, Non Hodgkin's
- Lymphoma, Non-Hodgkins
- Lymphoma, Non Hodgkins
- Non-Hodgkins Lymphoma
- Small Cleaved-Cell Lymphoma, Diffuse
- Small Cleaved Cell Lymphoma, Diffuse
- Lymphoma, Nonhodgkins
- Nonhodgkins Lymphoma
- Lymphoma, Small Cleaved Cell, Diffuse
- Lymphoma, Small Cleaved-Cell, Diffuse
- Non-Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- Non-Hodgkin's Lymphoma
- Non Hodgkin's Lymphoma
- Diffuse Small Cleaved-Cell Lymphoma
- Diffuse Small Cleaved Cell Lymphoma
- Lymphoma, Nonhodgkin's
- Lymphoma, Nonhodgkin
- Nonhodgkin's Lymphoma
Lymphoma, High-Grade- Lymphoma, High-Grade
- High-Grade Lymphoma
- High-Grade Lymphomas
- Lymphoma, High Grade
- Lymphomas, High-Grade
Lymphoma, Intermediate-Grade- Lymphoma, Intermediate-Grade
- Intermediate-Grade Lymphoma
- Intermediate-Grade Lymphomas
- Lymphoma, Intermediate Grade
- Lymphomas, Intermediate-Grade
Reticulum-Cell Sarcoma- Reticulum-Cell Sarcoma
- Reticulum Cell Sarcoma
- Reticulum-Cell Sarcomas
- Sarcomas, Reticulum-Cell
- Sarcoma, Reticulum-Cell
- Sarcoma, Reticulum Cell
- Reticulosarcoma
- Reticulosarcomas
Lymphoma, Mixed-Cell- Lymphoma, Mixed-Cell
- Lymphoma, Mixed Cell
- Lymphoma, Mixed Lymphocytic-Histiocytic
- Lymphocytic-Histiocytic Lymphoma, Mixed
- Lymphocytic-Histiocytic Lymphomas, Mixed
- Lymphoma, Mixed Lymphocytic Histiocytic
- Lymphomas, Mixed Lymphocytic-Histiocytic
- Mixed Lymphocytic-Histiocytic Lymphoma
- Mixed Lymphocytic-Histiocytic Lymphomas
- Mixed-Cell Lymphoma
- Lymphomas, Mixed-Cell
- Mixed Cell Lymphoma
- Mixed-Cell Lymphomas
- Lymphoma, Mixed
- Lymphomas, Mixed
- Mixed Lymphoma
- Mixed Lymphomas
Lymphoma, Mixed-Cell, Diffuse- Lymphoma, Mixed-Cell, Diffuse
- Diffuse Mixed Small and Large Cell Lymphoma
- Diffuse Mixed-Cell Lymphoma
- Diffuse Mixed Cell Lymphoma
- Diffuse Mixed-Cell Lymphomas
- Lymphoma, Diffuse Mixed-Cell
- Lymphomas, Diffuse Mixed-Cell
- Mixed-Cell Lymphomas, Diffuse
- Mixed-Cell Lymphoma, Diffuse
- Mixed Cell Lymphoma, Diffuse
- Lymphoma, Mixed Cell, Diffuse
- Lymphoma, Small and Large Cleaved-Cell, Diffuse
- Mixed Small and Large Cell Lymphoma, Diffuse
- Lymphoma, Mixed Small and Large Cell, Diffuse
- Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
Lymphoma, Small Noncleaved-Cell- Lymphoma, Small Noncleaved-Cell
- Lymphoma, Small Noncleaved Cell
- Diffuse Undifferentiated Lymphoma
- Diffuse Undifferentiated Lymphomas
- Lymphoma, Diffuse Undifferentiated
- Lymphomas, Diffuse Undifferentiated
- Undifferentiated Lymphoma, Diffuse
- Undifferentiated Lymphomas, Diffuse
- Lymphoma, Undifferentiated, Diffuse
- Small Non-Cleaved-Cell Lymphoma
- Small Non Cleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphoma
- Lymphomas, Small Noncleaved-Cell
- Noncleaved-Cell Lymphoma, Small
- Noncleaved-Cell Lymphomas, Small
- Small Noncleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphomas
- Lymphoma, Small Non-Cleaved-Cell
- Lymphoma, Small Non Cleaved Cell
- Lymphomas, Small Non-Cleaved-Cell
- Non-Cleaved-Cell Lymphoma, Small
- Non-Cleaved-Cell Lymphomas, Small
- Small Non-Cleaved-Cell Lymphomas
Lymphoma, Undifferentiated- Lymphoma, Undifferentiated
- Undifferentiated Lymphoma
- Lymphomas, Undifferentiated
- Undifferentiated Lymphomas
- Lymphoma, Pleomorphic
- Lymphomas, Pleomorphic
- Pleomorphic Lymphoma
- Pleomorphic Lymphomas
Lymphoma, Diffuse- Lymphoma, Diffuse
- Diffuse Lymphoma
- Diffuse Lymphomas
- Lymphomas, Diffuse
- Lymphosarcoma
- Lymphosarcomas
- Sarcoma, Lymphatic
- Lymphatic Sarcoma
- Lymphatic Sarcomas
- Sarcomas, Lymphatic
Lymphoma, Low-Grade- Lymphoma, Low-Grade
- Low-Grade Lymphoma
- Low-Grade Lymphomas
- Lymphoma, Low Grade
- Lymphomas, Low-Grade
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Non-Hodgkin".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Non-Hodgkin".
This graph shows the total number of publications written about "Lymphoma, Non-Hodgkin" by people in Harvard Catalyst Profiles by year, and whether "Lymphoma, Non-Hodgkin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 21 | 2 | 23 |
1994 | 24 | 6 | 30 |
1995 | 20 | 2 | 22 |
1996 | 15 | 2 | 17 |
1997 | 16 | 5 | 21 |
1998 | 17 | 0 | 17 |
1999 | 20 | 6 | 26 |
2000 | 12 | 2 | 14 |
2001 | 16 | 3 | 19 |
2002 | 10 | 6 | 16 |
2003 | 7 | 2 | 9 |
2004 | 13 | 2 | 15 |
2005 | 20 | 2 | 22 |
2006 | 16 | 5 | 21 |
2007 | 18 | 5 | 23 |
2008 | 19 | 8 | 27 |
2009 | 16 | 6 | 22 |
2010 | 20 | 8 | 28 |
2011 | 11 | 1 | 12 |
2012 | 16 | 5 | 21 |
2013 | 20 | 3 | 23 |
2014 | 19 | 2 | 21 |
2015 | 15 | 6 | 21 |
2016 | 9 | 2 | 11 |
2017 | 17 | 3 | 20 |
2018 | 16 | 5 | 21 |
2019 | 16 | 1 | 17 |
2020 | 24 | 2 | 26 |
2021 | 18 | 0 | 18 |
2022 | 14 | 0 | 14 |
Below are the most recent publications written about "Lymphoma, Non-Hodgkin" by people in Profiles.
-
The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease. Oncology (Williston Park). 2022 12 20; 36(12):718-727.
-
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 2022 12; 36(12):2835-2844.
-
Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. Int J Cancer. 2023 Mar 01; 152(5):865-878.
-
Let us give our Hodgkin's lymphoma patients the radiation they need. Leuk Lymphoma. 2022 12; 63(12):2763-2764.
-
Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma. Blood Adv. 2022 08 23; 6(16):4821-4830.
-
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR). Pediatr Blood Cancer. 2022 Nov; 69(11):e29901.
-
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV. J Natl Cancer Inst. 2022 06 13; 114(6):854-862.
-
Chronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma. Cutis. 2022 06; 109(6):E12-E14.
-
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial. Lancet Haematol. 2022 May; 9(5):e327-e339.
-
Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2022 06; 28(6):305.e1-305.e9.